Casdin Capital, LLC
Top Portfolio Positions
40 positions ·
$1,320,653,767 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
2,577,333 | $250,645,634 | 18.98% | |
| WGS |
GeneDx Holdings Corp.
Healthcare
|
3,007,164 | $193,120,072 | 14.62% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
14,418,574 | $143,464,811 | 10.86% | |
| BLFS |
Biolife Solutions Inc
Healthcare
|
5,957,165 | $113,662,708 | 8.61% | |
| LAB |
Standard Biotools Inc.
Healthcare
|
88,783,856 | $81,681,147 | 6.18% | |
| ILMN |
Illumina, Inc.
Healthcare
|
530,000 | $65,327,800 | 4.95% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
1,175,000 | $56,635,000 | 4.29% | |
| TXG |
10x Genomics, Inc.
Healthcare
|
2,275,000 | $48,298,250 | 3.66% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
1,840,000 | $35,328,000 | 2.68% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
1,350,000 | $32,170,500 | 2.44% |
Portfolio Trend
25 quarters · across all stocks
Holdings in RXRX
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $507,541 | 165,323 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $676,171 | 165,323 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $806,776 | 165,323 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $836,534 | 165,323 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $874,558 | 165,323 | Shares | Sole | 2025-05-15 | |
| 2022-03-31 | $3,924,796 | 548,156 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $9,389,912 | 548,156 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,613,069 | 548,156 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $20,007,694 | 548,156 | Shares | Sole | 2021-08-16 | |
| No 13F history on record for this holder in this stock. | ||||||